This open-label, single-arm study will evaluate the safety and efficacy of RoActemra/Actemra alone or concomitant with other antirheumatic drugs when administered as a single, weekly injection in patients with rheumatoid arthritis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01988012?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
